NYSE:TMOLife Sciences
How New Genomics Partnership And Asian Bioprocessing Push At Thermo Fisher Scientific (TMO) Has Changed Its Investment Story
In early December 2025, GENinCode announced a collaboration with Thermo Fisher Scientific to manufacture, sell and distribute the CARDIO inCode-Score polygenic risk test for coronary heart disease prediction across the US and EMEA, leveraging Thermo Fisher’s QuantStudio 5 Dx Real-Time PCR System and global footprint.
Alongside this, Thermo Fisher’s expansion of bioprocessing design centers in Asia reinforces its role as a global partner in both advanced diagnostics and biomanufacturing...